Literature DB >> 31154444

Predicting Remission Remains a Challenge in Patients with Juvenile Idiopathic Arthritis.

Stephanie J W Shoop-Worrall1, Kimme L Hyrich2.   

Abstract

Entities:  

Year:  2019        PMID： 31154444     DOI： 10.3899/jrheum.181245

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

Review 1.  Research progress in drug therapy of juvenile idiopathic arthritis.

Authors:  Wen-Jia Zhao; Jiang-Hong Deng; Cai-Feng Li
Journal:  World J Pediatr       Date:  2022-04-01       Impact factor: 2.764

Review 2.  Recent progress in the treatment of non-systemic juvenile idiopathic arthritis.

Authors:  John M Bridges; Elizabeth D Mellins; Randy Q Cron
Journal:  Fac Rev       Date:  2021-02-26

3.  Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study.

Authors:  Stephanie J W Shoop-Worrall; Kimme L Hyrich; Lucy R Wedderburn; Wendy Thomson; Nophar Geifman
Journal:  Lancet Rheumatol       Date:  2020-12-04

4.  Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alessandro Consolaro; Alessandra Alongi; Gabriella Giancane; Roberta Naddei; Valentina Natoli; Francesca Ridella; Marco Burrone; Silvia Rosina; Gaelle Chedeville; Ekaterina Alexeeva; Gerd Horneff; Ivan Foeldvari; Giovanni Filocamo; Tamàs Constantin; Nicolino Ruperto
Journal:  RMD Open       Date:  2022-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.